Recombinant Rat Tas2r114 is produced by expressing the Tas2r114 gene (Gene ID: 78982) in HEK293 cells, followed by purification using His (Fc)-Avi tags . Key features include:
This receptor is stabilized in PBS buffer with ≥85% purity and endotoxin levels <1.0 EU/μg . Its recombinant form enables functional studies of bitter compound interactions and signaling mechanisms.
Tas2r114 exhibits low basal expression in lingual taste cells but higher activity in extraoral tissues . It detects cucurbitacins (bitter plant compounds) with higher efficacy than other Tas2rs .
CRISPR/Cas9-generated Tas2r104/105/114 cluster knockout mice revealed:
Loss of bitter perception: Eliminated responses to cucurbitacin B (CuB), denatonium benzoate, and quinine .
Compensatory mechanisms: Altered expression of other Tas2r genes (e.g., Tas2r108, Tas2r137) in taste buds .
Extraoral roles: Moderate-to-high expression in kidney and gut suggests non-gustatory functions .
Ligand Screening: Identifies agonists/antagonists via calcium flux assays .
Structural Studies: Supports cryo-EM and mutagenesis to map binding pockets (e.g., dual flufenamic acid binding in human TAS2R14 homolog) .
Pathway Analysis: Part of the taste transduction pathway involving PLCβ2 and GNAT3 .
Tas2r114 in rats, similar to its mouse ortholog, shows differential expression patterns across tissues. While having relatively low expression levels in lingual papillae and gustatory tissue, Tas2r114 exhibits more robust expression in extraoral tissues such as testis, kidney, and gut . This expression pattern suggests that Tas2r114 likely serves diverse physiological functions beyond taste perception.
In comparative studies, mouse Tas2r114 demonstrates one of the lowest expression levels among bitter taste receptors in taste buds, making it challenging to detect through conventional methods . When designing experiments to characterize rat Tas2r114 expression, researchers should consider using highly sensitive methods such as quantitative RT-PCR with properly designed primers and validated reference genes, as well as RNAscope in situ hybridization for spatial localization within tissues.
For detecting endogenous Tas2r114 in rat tissues, a multi-method approach is recommended:
For extraoral tissues where Tas2r114 shows higher expression (e.g., testis, kidney), detection sensitivity requirements may be less stringent than for taste tissues.
Based on studies with mouse Tas2r114, several bitter compounds have been identified as potential agonists that may also activate rat Tas2r114:
| Compound Class | Examples | Effective Concentration Range | Relative Efficacy |
|---|---|---|---|
| Cucurbitacins | Cucurbitacin B, D, E, I | Low micromolar | High |
| Alkaloids | Quinine | 3-10 μM | Moderate |
| Other bitters | Denatonium benzoate | Low millimolar | Moderate |
When characterizing rat Tas2r114 agonist profiles, researchers should systematically test a diverse panel of bitter compounds, starting with those known to activate mouse Tas2r114, and employ dose-response analyses to determine potency and efficacy parameters.
For functional characterization of recombinant rat Tas2r114, several heterologous expression systems have demonstrated effectiveness for bitter taste receptors:
HEK293T cells expressing Gα16gust44: This system provides superior sensitivity compared to cells expressing only Gα15, particularly for detecting responses to low-efficacy agonists. The chimeric G protein (Gα16gust44) facilitates coupling between the taste receptor and phospholipase C (PLC) signaling pathway .
Calcium imaging assay parameters:
Transfection: Co-transfect Tas2r114 with Gα16gust44 (3:1 ratio)
Fluorescent indicator: Fura-2/AM (5 μM loading for 30 minutes)
Signal detection: Ratiometric measurement (340/380 nm)
Analysis: Calculate ΔF/F values and determine EC50 values from dose-response curves
Key controls to include:
Empty vector transfected cells
Cells expressing known functional bitter receptors (e.g., Tas2r105)
Multiple biological replicates (minimum n=3)
The choice of expression system significantly impacts detection sensitivity. For Tas2r114, which may respond to agonists with lower efficacy, the Gα16gust44 system is particularly important for reliable detection of responses .
For successful production of functional recombinant rat Tas2r114, consider these expression system components:
Vector selection:
pCDNA3.1: Widely used for mammalian expression with CMV promoter
pEF1α-based vectors: Provide more sustained expression compared to CMV promoter
Inducible expression systems: T-REx or Tet-On systems allow controlled expression levels
Epitope tags:
N-terminal tags: Rhodopsin or FLAG tags improve membrane trafficking
C-terminal tags: His6 or 1D4 tags facilitate purification
Location considerations: Position tags to avoid disrupting signal peptides or membrane topology
SSB-Tas2r114 fusion approach:
Creating a fusion protein with the first 45 amino acids of somatostatin receptor type 3 (SSB) increases surface expression
This approach has been successful for other bitter taste receptors and may enhance rat Tas2r114 membrane targeting
Codon optimization:
Optimize codons for the expression host (mammalian cells)
Eliminate cryptic splice sites and destabilizing RNA elements
When designing constructs, incorporate flanking restriction sites to facilitate subcloning and consider a fluorescent protein fusion (e.g., GFP) to monitor expression and localization, with appropriate controls to ensure the fusion doesn't impair receptor function.
Purification of functional GPCRs like Tas2r114 requires careful optimization:
Membrane preparation:
Harvest cells 48-72 hours post-transfection
Prepare membranes using nitrogen cavitation or mechanical disruption
Include protease inhibitors throughout all steps
Detergent screening:
| Detergent | Concentration | Advantages | Considerations |
|---|---|---|---|
| DDM | 1% | Widely used for GPCRs | May destabilize Tas2r114 |
| LMNG | 0.5-1% | Enhanced stability | Higher cost |
| Digitonin | 0.5% | Gentle extraction | Lower yield |
| GDN | 0.1% | Preserves function | Recent development |
Stabilization approaches:
Addition of specific ligands during purification
Inclusion of cholesteryl hemisuccinate (CHS)
Glycerol (10%) as a stabilizing agent
Lipid nanodiscs or SMALPs for a more native-like environment
Purification strategy:
IMAC purification via His-tag
Optional second step: Size exclusion chromatography
Quality control: SDS-PAGE, Western blot, and functional assays
The recent structural characterization of human TAS2R14 provides valuable insights that can be applied to rat Tas2r114 purification, particularly regarding detergent selection and stabilization approaches.
Tas2r114 belongs to a genomically clustered group of bitter taste receptor genes with interesting evolutionary features:
Genomic organization:
Orthology relationships:
Evolutionary significance:
When studying rat Tas2r114, researchers should consider its evolutionary context, particularly how its function may have diverged from related receptors following duplication events, as this can provide insights into species-specific adaptations in bitter taste perception.
Although direct structural information for rat Tas2r114 is not yet available, insights from related receptors provide valuable comparative information:
Binding pocket characteristics:
The recent cryo-EM structure of human TAS2R14 reveals a dual binding mode for flufenamic acid (FFA), with binding sites in both the transmembrane bundle and the intracellular facet
Rat Tas2r114 likely shares similar structural architecture but with species-specific variations in binding pocket residues
Critical binding residues:
| Domain | Human TAS2R14 Residues | Potential Rat Tas2r114 Equivalents | Functional Significance |
|---|---|---|---|
| TM3 | Residues forming canonical pocket | May show substitutions | Altered ligand specificity |
| TM6-TM7 interface | Residues contacting G protein | More conserved | Maintained signaling |
| Extracellular loops | Variable regions | Highly divergent | Species-specific recognition |
Functional implications:
When conducting structure-function studies of rat Tas2r114, researchers should focus on identifying the specific residues that contribute to species-specific differences in ligand recognition through mutagenesis approaches and comparative homology modeling based on the human TAS2R14 structure .
CRISPR/Cas9 gene editing offers powerful approaches for studying Tas2r114 function:
Design strategy for Tas2r114-specific targeting:
Knock-out vs. knock-in approaches:
| Approach | Advantages | Considerations | Application |
|---|---|---|---|
| Complete knockout | Eliminates all function | May affect cluster regulation | Phenotypic screening |
| Point mutations | Alters specific functions | Requires precise editing | Structure-function studies |
| Reporter knock-in | Maintains expression pattern | Complex design | Expression analysis |
| Conditional knockout | Tissue-specific deletion | Requires Cre-loxP system | Isolate tissue-specific roles |
Verification methods:
Challenges specific to Tas2r114:
Genomic clustering may require specialized approaches to avoid affecting neighboring genes
Low expression levels in some tissues necessitate sensitive detection methods
Functional redundancy with other Tas2rs may mask phenotypes in single-gene knockouts
When targeting the Tas2r104/Tas2r105/Tas2r114 cluster, consider a strategy similar to the one described in search result , where researchers successfully generated mutant mice with altered taste perception to specific bitter compounds.
Bitter taste receptors including Tas2r114 have emerged as important signaling molecules beyond the oral cavity:
Extraoral expression sites and potential functions:
Signaling mechanisms in extraoral tissues:
May utilize alternative signaling pathways compared to taste cells
Often couples to different G proteins in a tissue-specific manner
May involve calcium signaling, cAMP production, or alternative second messengers
Research approaches using recombinant Tas2r114:
Cell-type specific expression profiling using sorted populations
Primary cell cultures from extraoral tissues transfected with recombinant Tas2r114
Ex vivo tissue preparations with application of identified Tas2r114 agonists
Development of tissue-specific transgenic reporter models
Physiological significance:
Potential roles in metabolite sensing and detoxification
Involvement in cellular homeostasis and tissue-specific functions
Possible pathophysiological relevance in disease states
Given the differential expression of Tas2r114 across tissues, researchers should investigate tissue-specific signaling partners and downstream pathways that may differ from those in taste cells when studying extraoral functions.
Researchers frequently encounter discrepancies between in vitro characterization and in vivo function of taste receptors. Several methodological approaches can help resolve these contradictions:
Sources of discrepancy:
Expression system artifacts in heterologous cells
Differences in G protein coupling efficiency
Absence of accessory proteins and modulators
Compensatory mechanisms in knockout models
Reconciliation strategies:
Comparative approaches:
Test compounds identified in vitro using behavioral assays
Perform ex vivo tissue preparations with calcium imaging
Develop knock-in models expressing modified receptors
Use pharmacological inhibitors to validate in vivo pathways
Integrated data analysis:
Correlate potency/efficacy data from in vitro assays with behavioral thresholds
Account for pharmacokinetic/bioavailability factors in in vivo studies
Consider circuit-level effects for behavioral readouts
The case of Tas2r105 in mice provides an instructive example: initially reported as highly selective for cycloheximide, it was later shown to respond to multiple bitter compounds when tested in a more sensitive assay system . Similarly, for rat Tas2r114, careful comparison of assay conditions and systematic testing with appropriate controls can help resolve apparent contradictions between different experimental approaches.
Researchers working with recombinant rat Tas2r114 frequently encounter these technical challenges:
Low surface expression issues:
| Challenge | Solution | Validation Method |
|---|---|---|
| Poor membrane trafficking | N-terminal rhodopsin tag (first 39 amino acids) | Immunofluorescence, ELISA |
| Protein misfolding | Reduce culture temperature (30°C instead of 37°C) | Functional response amplitude |
| Rapid degradation | Proteasome inhibitors (MG132) for short-term studies | Western blot of total vs. surface protein |
| Low translation efficiency | Codon optimization for expression system | qRT-PCR vs. protein level comparison |
Signal detection optimization:
Agonist screening challenges:
Solubility issues: Prepare stock solutions in DMSO (final DMSO <0.1%)
Compound stability: Prepare fresh solutions for unstable compounds
Autofluorescence: Account for compound fluorescence in analysis
Non-specific effects: Include non-transfected cell controls
Reproducibility factors:
Cell passage number affects receptor expression (use cells between passages 5-15)
Transfection efficiency variation (use internal transfection markers)
Receptor desensitization (allow sufficient recovery between stimulations)
Proper vehicle controls for all test compounds
By systematically addressing these technical challenges, researchers can improve the reliability and sensitivity of heterologous expression systems for rat Tas2r114 functional characterization.
Several cutting-edge technologies are poised to transform Tas2r114 research:
Structural biology innovations:
Single-cell technologies:
| Technology | Application to Tas2r114 Research | Potential Insights |
|---|---|---|
| scRNA-seq | Cell-type specific expression patterns | Novel expressing cell populations |
| Spatial transcriptomics | Positional information in tissues | Functional microdomains |
| CyTOF/CITE-seq | Protein-level quantification | Correlation with other signaling components |
| Live-cell imaging | Real-time signaling dynamics | Temporal signaling patterns |
Physiological assessment tools:
Genetically encoded calcium indicators in specific cell types
Optogenetic manipulation of Tas2r114-expressing cells
Tissue-specific conditional knockout models
Organoid cultures from Tas2r114-expressing tissues
Translational applications:
Drug screening platforms using recombinant Tas2r114
Bioengineered sensors for environmental bitter compounds
Therapeutic targeting of extraoral Tas2r114 functions
Comparative medicine approaches across species
These emerging technologies will enable researchers to address fundamental questions about Tas2r114 function in both gustatory and extraoral contexts, potentially revealing novel physiological roles and therapeutic applications.
Systems biology approaches offer powerful frameworks for understanding Tas2r114 within larger physiological networks:
Multi-omics integration:
Transcriptomics of Tas2r114-expressing tissues under various conditions
Proteomics to identify interaction partners and signaling complexes
Metabolomics to discover endogenous ligands and metabolic impacts
Integration of datasets to build predictive network models
Pathway analysis approaches:
| Approach | Application | Expected Outcome |
|---|---|---|
| ChIP-seq/ATAC-seq | Regulatory mechanisms | Transcriptional control elements |
| Phosphoproteomics | Signaling cascades | Novel pathway components |
| Interactomics | Protein-protein interactions | Regulatory protein complexes |
| Flux analysis | Metabolic consequences | System-level responses |
Mathematical modeling:
Kinetic models of Tas2r114 signaling dynamics
Agent-based models of tissue-level responses
Pharmacokinetic/pharmacodynamic models for in vivo effects
Machine learning approaches to predict ligand interactions
Integrative physiological assessment:
Correlation of taste sensitivity with metabolic parameters
Effects of Tas2r114 activation on organ system functions
Interactions between taste perception and gut hormone signaling
Neural circuit mapping of Tas2r114-mediated responses
By implementing these systems approaches, researchers can move beyond reductionist views of Tas2r114 function to understand its role in integrated physiological processes and potential involvement in pathological conditions.